An experimental drug originally developed by Sanofi that is now being advanced by the Mayo Clinic significantly curbed ...

Stocks like Schaeffler India, GE Power India, Coal India, Servotech Renewable Power System, Chemplast Sanmar, Rail Vikas ...

Adolescents and adults with eosinophilic esophagitis improved with dupilumab regardless of whether they were practicing food ...

The building in Woodcliff Lake rose in value despite the trend away from suburban office space with work-from-home and a ...

Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...

Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total ...

Sanofi’s cardiovascular (CV) and central nervous system (CNS) therapies have gained traction, supported by partnerships.

This month on pharmaphorum, we explore the history of French pharmaceutical company Sanofi, which was created through many partnerships and acquisitions over a period of 100 years. Sanofi is one ...

In ulcerative colitis, duvakitug led to clinical remission in up to 48% of patients, with placebo-adjusted rates of 27% at the highest dose. In Crohn's disease, duvakitug achieved endoscopic ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...